Director Kenneth Van Heel awarded 3,000 RSUs at SeaStar Medical (ICU)

Rhea-AI Filing Summary

SeaStar Medical Holding Corp director Kenneth Van Heel reported receiving a grant of restricted stock units (RSUs) under the company’s equity program. On February 6, 2026, he acquired 3,000 shares of common stock at a price of $0 as an award.

According to the filing, these RSUs will vest in full on February 6, 2027, meaning the shares become fully owned on that date if vesting conditions are met. After this grant, Van Heel beneficially owns 7,940 shares of SeaStar Medical common stock directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Van Heel Kenneth

(Last) (First) (Middle)

3513 BRIGHTON BLVD

SUITE 410

(Street)

DENVER C0 80216

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SeaStar Medical Holding Corp [ ICU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, par value $0.0001	02/06/2026		A		3,000(1)	A	$0	7,940	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a RSU award. The RSUs will vest in full on February 6, 2027.

	/s/ Eric Schlorff as-attorney-in-fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SeaStar Medical (ICU) director Kenneth Van Heel report on this Form 4?

Kenneth Van Heel reported receiving 3,000 restricted stock units of SeaStar Medical common stock as an award. The grant was made on February 6, 2026, at a price of $0 per share, increasing his directly held beneficial ownership to 7,940 shares.

How many SeaStar Medical (ICU) shares did Kenneth Van Heel acquire and at what price?

He acquired 3,000 shares of SeaStar Medical common stock through a restricted stock unit award at a price of $0 per share. This equity grant reflects compensation rather than an open-market purchase, and it raised his direct beneficial ownership to 7,940 shares.

When do Kenneth Van Heel’s SeaStar Medical (ICU) RSUs vest?

The restricted stock units granted to Kenneth Van Heel vest in full on February 6, 2027. Once vested, the RSUs convert into freely owned shares, assuming any applicable service or other vesting conditions specified by the company’s award terms are satisfied.

What is Kenneth Van Heel’s total SeaStar Medical (ICU) share ownership after this RSU award?

Following the RSU award, Kenneth Van Heel beneficially owns 7,940 shares of SeaStar Medical common stock directly. This figure reflects his holdings after adding the 3,000-share restricted stock unit grant reported in the Form 4 for the February 6, 2026 transaction.

Is the SeaStar Medical (ICU) RSU grant to Kenneth Van Heel a purchase or compensation?

The 3,000-share grant is compensation in the form of restricted stock units, not a market purchase. It was awarded at a price of $0 per share, consistent with equity incentives often provided to directors as part of their overall compensation packages.

What role does Kenneth Van Heel hold at SeaStar Medical (ICU) according to this filing?

Kenneth Van Heel is identified as a director of SeaStar Medical Holding Corp in this Form 4. The reported transaction reflects equity compensation associated with his board role, rather than trading activity as a 10% owner or company officer.